Zometa/Aredia

On January 25, 2008, the Supreme Court designated all litigation, pending and future, statewide involving the drugs, Zometa/Aredia as mass tort and assigned it for centralized, coordinated handling to Judge Jamie D. Happas in the Middlesex vicinage. This litigation involves claims filed largely against the manufacturer of these pharmaceuticals for alleged damages and injuries arising from their use.

Privacy Policy | Contact Us | © New Jersey Judiciary